Flavones suppress type I IL-4 receptor signaling by down-regulating the expression of common gamma chain

FEBS Letters

Volumn 584, Issue 4, 2010, Pages 775-779

  Yamashita, Shuya ^a   Yamashita, Tatsunori ^a   Yamada, Koji ^a   Tachibana, Hirofumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Germline transcript; Common gamma chain; Flavones; Immunoglobulin E; Interleukin 4 signaling; Signal transducer and activator of transcription 6

Indexed keywords

FLAVONE DERIVATIVE; IMMUNOGLOBULIN E; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA; JANUS KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; STAT6 PROTEIN;

ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

APIGENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; DOWN-REGULATION; FLAVONES; FLAVONOIDS; GENE EXPRESSION; HELA CELLS; HUMANS; IMMUNOGLOBULIN EPSILON-CHAINS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKIN-4; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; JANUS KINASE 3; PHOSPHORYLATION; PPAR GAMMA; RECEPTORS, INTERLEUKIN-4, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 77649270386     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.12.044     Document Type: Article

References (21)

1. Holgate S.T. The epidemic of allergy and asthma. Nature 1999, 402:B2-B4.
2. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999, 17:701-738.
3. Gauchat J.F., Lebman D.A., Coffman R.L., Gascan H., de Vries J.E. Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production. J. Exp. Med. 1990, 172:463-473.
4. Hershey G.K. IL-13 receptors, signaling pathways: an evolving web. J. Allergy Clin. Immunol. 2003, 111:677-690.
5. Junttila I.S., Mizukami K., Dickensheers H., Meier-Schellersheim M., Yamane H., Donnelly R.P., Paul W.E. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J. Exp. Med. 2008, 205:2595-2608.
6. Caltagirone S., Rossi C., Poggi A., Ranelletti F.O., Natali P.G., Brunetti M., Aiello F.B., Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer 2000, 87:595-600.
7. Hougee S., Sanders A., Faber J., Graus Y.M., van den Berg W.B., Garssen J., Friso, Smit H., Hoijer M.A. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem. Pharmacol. 2005, 69:241-248.
8. Yano S., Umeda D., Maeda N., Fujimura Y., Yamada K., Tachibana H. Dietary apigenin suppresses IgE and inflammatory cytokines production in C57BL/6N mice. J. Agric. Food. Chem. 2006, 54:5203-5207.
9. Yano S., Umeda D., Yamashita T., Ninomiya Y., Sumida M., Fujimura Y., Yamada K., Tachibana H. Dietary flavones suppresses IgE and Th2 cytokines in OVA-immunized BALB/c mice. Eur. J. Nutr. 2007, 46:257-263.
10. Yano S., Umeda D., Yamashita S., Yamada K., Tachibana H. Dietary apigenin attenuates the development of atopic dermatitis-like skin lesions in NC/Nga mice. J. Nutr. Biochem. 2009, 20:876-881.
11. Tachibana H., Kubo T., Miyase T., Tanino S., Yoshimoto M., Sano M., Yamamoto-Maeda M., Yamada K. Identification of an inhibitor for interleukin 4-induced ε germline transcription and antigen-specific IgE production in vivo. Biochem. Biophys. Res. Commun. 2001, 280:53-60.
12. Fenghao X., Saxon A., Nguyen A., Ke Z., Diaz-Sanchez D., Nel A. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-γ activation site-like sequence upstream of the Iε exon in a human B cell line. J. Clin. Invest. 1995, 96:907-914.
13. Linehan L.A., Warren W.D., Thompson P.A., Grusby M.J., Berton M.T. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 1998, 161:302-310.
14. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A., Doherty P.C., Grosveld G., Paul W.E., Ihle J.N. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996, 380:630-633.
15. Liang Y.C., Tsai S.H., Tsai D.C., Lin-Shiau S.Y., Lin J.K. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-γ by flavonoids in mouse macrophages. FEBS Lett. 2001, 496:2-18.
16. Miyazaki Y., Tachibana H., Yamada K. Inhibitory effect of peroxisome proliferator-activated receptor-γ ligands on the expression of IgE heavy chain germline transcripts in the human B cell line DND39. Biochem. Biophys. Res. Commun. 2002, 297:193-201.
17. Asao H., Okuyama C., Kumaki S., Ishii N., Tsuchiya S., Foster D., Sugamura K. The common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 2001, 167:1-5.
18. Cortes J.R., Perez-G M., Rivas M.D., Zamorano J. Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol. 2007, 179:3881-3887.
19. Kotani M., Matsumoto M., Fujita A., Higa S., Wang W., Suemura M., Kishimoto T., Tanaka T. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allergy Clin. Immunol. 2000, 106:159-166.
20. Holgate S.T., Djukanovic R., Casale T., Bousque J. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin. Exp. Allergy 2005, 35:408-416.
21. Kudlacz E., Conklyn M., Anderson C., Whitney-Pickett C., Changelian P. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of phlmonary eosinopholia. Eur. J. Pharmacol. 2008, 582:154-161.